Compare CG & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CG | WST |
|---|---|---|
| Founded | 1987 | 1923 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.6B | 20.2B |
| IPO Year | 2012 | N/A |
| Metric | CG | WST |
|---|---|---|
| Price | $58.23 | $266.98 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 16 | 10 |
| Target Price | $66.79 | ★ $346.78 |
| AVG Volume (30 Days) | ★ 2.7M | 635.1K |
| Earning Date | 10-31-2025 | 10-23-2025 |
| Dividend Yield | ★ 2.40% | 0.33% |
| EPS Growth | ★ 445.01 | 0.17 |
| EPS | 1.78 | ★ 6.75 |
| Revenue | ★ $3,208,300,000.00 | $3,017,900,000.00 |
| Revenue This Year | N/A | $7.01 |
| Revenue Next Year | $20.80 | $6.20 |
| P/E Ratio | ★ $32.76 | $39.63 |
| Revenue Growth | N/A | ★ 4.92 |
| 52 Week Low | $33.02 | $187.43 |
| 52 Week High | $69.85 | $348.90 |
| Indicator | CG | WST |
|---|---|---|
| Relative Strength Index (RSI) | 60.04 | 45.27 |
| Support Level | $55.90 | $263.38 |
| Resistance Level | $60.56 | $274.56 |
| Average True Range (ATR) | 1.75 | 7.32 |
| MACD | 0.82 | -0.79 |
| Stochastic Oscillator | 76.41 | 15.52 |
Carlyle Group is one of the world's largest alternative-asset managers, with $474.1 billion in total AUM, including $332.0 billion in fee-earning AUM, at the end of September 2025. The company has three core business segments: global private equity, which includes its private equity, real estate, infrastructure, and natural resources offerings (with $163.5 billion in total AUM and $101.1 billion in fee-earning AUM), global credit ($208.5 billion/$167.2 billion), and investment/fund solutions, known as Carlyle AlphInvest ($102.1 billion/$63.7 billion). The firm primarily serves institutional investors and high-net-worth individuals. Carlyle operates through 29 offices across five continents, serving more than 3,100 active carry fund investors from 87 countries.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.